One Small Pharma Stock Has Big Potential

In today's small cap focus column, we take a deeper look at Redhill Biopharma (RDHL) . This is a small, Israeli-based biopharma concern I have commented on before, but it is time for a more detailed analysis. The stock has been on the move of late, but is still far below where analysts think it can rise to eventually.

More importantly, the company has numerous traits I look for before I take a small stake in an emerging developmental stock in this high-beta sector of the market. These include multiple "shots on goal", upcoming catalysts and addressable markets. I really like how the company's pipeline is developing. The shares seem "off the radar" to most investors in this space, as well....373 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.